{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T17:40:11Z","timestamp":1742146811654,"version":"3.38.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T00:00:00Z","timestamp":1324944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12020-011-9585-8","type":"journal-article","created":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T15:21:23Z","timestamp":1324912883000},"page":"465-472","source":"Crossref","is-referenced-by-count":4,"title":["Does Apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly?"],"prefix":"10.1007","volume":"41","author":[{"given":"Vildan","family":"Bozok Cetintas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Zengi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli","family":"Tetik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muammer","family":"Karadeniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruk","family":"Ergonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Sahin","family":"Kucukaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadik","family":"Tamsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buket","family":"Kosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap Baydur","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusun","family":"Sayg\u0131l\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhal","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,27]]},"reference":[{"issue":"5","key":"9585_CR1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.beem.2009.05.010","volume":"23","author":"P Chanson","year":"2009","unstructured":"P. Chanson, S. Salenave, P. Kamenicky, L. Cazabat, J. Young, Pituitary tumours: acromegaly. Best Pract. Res. 23(5), 555\u2013574 (2009)","journal-title":"Best Pract. Res."},{"issue":"Suppl. 1","key":"9585_CR2","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1530\/eje.0.151S093","volume":"151","author":"A Colao","year":"2004","unstructured":"A. Colao, G. Vitale, R. Pivonello, A. Ciccarelli, C. Di Somma, G. Lombardi, The heart: an end-organ of GH action. Eur. J. Endocrinol.\/Eur. Fed. Endocr. Soc. 151(Suppl. 1), S93\u2013S101 (2004)","journal-title":"Eur. J. Endocrinol.\/Eur. Fed. Endocr. Soc."},{"issue":"4","key":"9585_CR3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-2275(20)40067-7","volume":"36","author":"RW Mahley","year":"1995","unstructured":"R.W. Mahley, K.E. Palaoglu, Z. Atak, J. Dawson-Pepin, A.M. Langlois, V. Cheung, H. Onat, P. Fulks, L.L. Mahley, F. Vakar et al., Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 36(4), 839\u2013859 (1995)","journal-title":"J. Lipid Res."},{"issue":"20","key":"9585_CR4","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1016\/S0021-9258(17)44180-9","volume":"258","author":"TL Innerarity","year":"1983","unstructured":"T.L. Innerarity, E.J. Friedlander, S.C. Rall Jr., K.H. Weisgraber, R.W. Mahley, The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J. Biol. Chem. 258(20), 12341\u201312347 (1983)","journal-title":"J. Biol. Chem."},{"issue":"2","key":"9585_CR5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1172\/JCI113107","volume":"80","author":"YA Kesaniemi","year":"1987","unstructured":"Y.A. Kesaniemi, C. Ehnholm, T.A. Miettinen, Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Investig. 80(2), 578\u2013581 (1987)","journal-title":"J. Clin. Investig."},{"issue":"6","key":"9585_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0029-1211774","volume":"105","author":"J Wildbrett","year":"1997","unstructured":"J. Wildbrett, M. Hanefeld, K. Fucker, T. Pinzer, S. Bergmann, G. Siegert, M. Breidert, Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I. Exp. Clin. Endocrinol. Diabetes 105(6), 331\u2013335 (1997)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"3","key":"9585_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02738787","volume":"8","author":"C Rocken","year":"1997","unstructured":"C. Rocken, D. Paris, K. Steusloff, W. Saeger, Investigation of the presence of apotipoprotein E, G lycosaminoglycans, basement membrane proteins, and protease inhibitors in senile interstitial amyloid of the pituitary. Endocr. Pathol. 8(3), 205\u2013214 (1997)","journal-title":"Endocr. Pathol."},{"issue":"1","key":"9585_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s004280050212","volume":"433","author":"K Steusloff","year":"1998","unstructured":"K. Steusloff, C. Rocken, W. Saeger, Basement membrane proteins, apolipoprotein E and glycosaminoglycans in pituitary adenomas and their correlation to amyloid. Virchows Arch. 433(1), 29\u201334 (1998)","journal-title":"Virchows Arch."},{"issue":"7","key":"9585_CR9","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95(7), 3141\u20133148 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"9585_CR10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.surneu.2009.07.006","volume":"72","author":"FH Ebner","year":"2009","unstructured":"F.H. Ebner, V. Kuerschner, K. Dietz, E. Bueltmann, T. Naegele, J. Honegger, Reduced intercarotid artery distance in acromegaly: pathophysiologic considerations and implications for transsphenoidal surgery. Surg. Neurol. 72(5), 456\u2013460 (2009). discussion 460","journal-title":"Surg. Neurol."},{"issue":"15","key":"9585_CR11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/archinternmed.2009.234","volume":"169","author":"H Ward","year":"2009","unstructured":"H. Ward, P.N. Mitrou, R. Bowman, R. Luben, N.J. Wareham, K.T. Khaw, S. Bingham, APOE genotype, lipids, and coronary heart disease risk: a prospective population study. Arch. Intern. Med. 169(15), 1424\u20131429 (2009)","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"9585_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102\u2013152 (2004)","journal-title":"Endocr. Rev."},{"issue":"10","key":"9585_CR13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2217\/14622416.9.10.1475","volume":"9","author":"T Nieminen","year":"2008","unstructured":"T. Nieminen, M. Kahonen, L.E. Viiri, P. Gronroos, T. Lehtimaki, Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease. Pharmacogenomics 9(10), 1475\u20131486 (2008)","journal-title":"Pharmacogenomics"},{"issue":"6","key":"9585_CR14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/aje\/155.6.487","volume":"155","author":"JE Eichner","year":"2002","unstructured":"J.E. Eichner, S.T. Dunn, G. Perveen, D.M. Thompson, K.E. Stewart, B.C. Stroehla, Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 155(6), 487\u2013495 (2002)","journal-title":"Am. J. Epidemiol."},{"issue":"12","key":"9585_CR15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/hr.2009.164","volume":"32","author":"W Niu","year":"2009","unstructured":"W. Niu, Y. Qi, Y. Qian, P. Gao, D. Zhu, The relationship between apolipoprotein E epsilon2\/epsilon3\/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens. Res. 32(12), 1060\u20131066 (2009)","journal-title":"Hypertens. Res."},{"issue":"1\u20133","key":"9585_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.forsciint.2009.07.020","volume":"192","author":"S Heide","year":"2009","unstructured":"S. Heide, K. Manfred, C. Glaser, S. Schulz, Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis? Forensic Sci. Int. 192(1\u20133), 62\u201366 (2009)","journal-title":"Forensic Sci. Int."},{"issue":"10","key":"9585_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/jhg.2009.83","volume":"54","author":"P Georgoulias","year":"2009","unstructured":"P. Georgoulias, G. Wozniak, M. Samara, I. Chiotoglou, A. Kontos, C. Tzavara, V. Valotassiou, M. Georgitsi, V. Aleporou-Marinou, G.P. Patrinos, P. Kollia, Impact of ACE and ApoE polymorphisms on myocardial perfusion: correlation with myocardial single photon emission computed tomographic imaging. J. Hum. Genet. 54(10), 595\u2013602 (2009)","journal-title":"J. Hum. Genet."},{"issue":"11","key":"9585_CR18","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/01.ATV.19.11.2762","volume":"19","author":"R Yang","year":"1999","unstructured":"R. Yang, L. Powell-Braxton, A.K. Ogaoawara, N. Dybdal, S. Bunting, O. Ohneda, H. Jin, Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 19(11), 2762\u20132768 (1999)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"9585_CR19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","volume":"28","author":"ES Ford","year":"2005","unstructured":"E.S. Ford, Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28(7), 1769\u20131778 (2005)","journal-title":"Diabetes Care"},{"issue":"1","key":"9585_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-511X-10-9","volume":"10","author":"HM Zeljko","year":"2011","unstructured":"H.M. Zeljko, T. Skaric-Juric, N.S. Narancic, Z. Tomas, A. Baresic, M.P. Salihovic, B. Starcevic, B. Janicijevic, E2 allele of the Apolipoprotein E gene polymorphism is predictive for obesity status in Roma minority population of Croatia. Lipids Health Dis. 10(1), 9 (2011)","journal-title":"Lipids Health Dis."},{"issue":"4","key":"9585_CR21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1253\/jcj.54.448","volume":"54","author":"T Yamamura","year":"1990","unstructured":"T. Yamamura, S. Tajima, Y. Miyake, S. Nomura, A. Yamamoto, K. Haze, K. Hiramori, Hyperlipoproteinemia as a risk factor for ischemic heart disease. Jpn. Circ. J. 54(4), 448\u2013456 (1990)","journal-title":"Jpn. Circ. J."},{"issue":"10","key":"9585_CR22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.ATV.16.10.1250","volume":"16","author":"PW Wilson","year":"1996","unstructured":"P.W. Wilson, E.J. Schaefer, M.G. Larson, J.M. Ordovas, Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler. Thromb. Vasc. Biol. 16(10), 1250\u20131255 (1996)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"9585_CR23","first-page":"83","volume":"61","author":"M Kaluzny","year":"2010","unstructured":"M. Kaluzny, M. Bolanowski, J. Daroszewski, A. Szuba, The role of fibrinogen and CRP in cardiovascular risk in patients with acromegaly. Endokrynol. Pol. 61(1), 83\u201388 (2010)","journal-title":"Endokrynol. Pol."},{"issue":"3","key":"9585_CR24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.humimm.2010.01.008","volume":"71","author":"JA Hubacek","year":"2010","unstructured":"J.A. Hubacek, A. Peasey, H. Pikhart, P. Stavek, R. Kubinova, M. Marmot, M. Bobak, APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Hum. Immunol. 71(3), 304\u2013308 (2010)","journal-title":"Hum. Immunol."},{"issue":"2","key":"9585_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2004.07.012","volume":"177","author":"R Judson","year":"2004","unstructured":"R. Judson, C. Brain, B. Dain, A. Windemuth, G. Ruano, C. Reed, New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis 177(2), 345\u2013351 (2004)","journal-title":"Atherosclerosis"},{"issue":"2","key":"9585_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/CCLM.2008.033","volume":"46","author":"P Gronroos","year":"2008","unstructured":"P. Gronroos, O.T. Raitakari, M. Kahonen, N. Hutri-Kahonen, J. Marniemi, J. Viikari, T. Lehtimaki, Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: the Cardiovascular Risk in Young Finns Study. Clin. Chem. Lab. Med. 46(2), 179\u2013186 (2008)","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"9585_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02455.x","volume":"64","author":"R Rontu","year":"2006","unstructured":"R. Rontu, P. Ojala, A. Hervonen, S. Goebeler, P.J. Karhunen, M. Nikkila, T. Kunnas, M. Jylha, C. Eklund, M. Hurme, T. Lehtimaki, Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians. Clin. Endocrinol. 64(3), 265\u2013270 (2006)","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"9585_CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/187152910793743841","volume":"10","author":"A Agrawal","year":"2010","unstructured":"A. Agrawal, D.J. Hammond Jr., S.K. Singh, Atherosclerosis-related functions of C-reactive protein. Cardiovasc. Hematol. Disord. Drug Targ. 10(4), 235\u2013240 (2010)","journal-title":"Cardiovasc. Hematol. Disord. Drug Targ."},{"issue":"2","key":"9585_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-141-2-200407200-00013","volume":"141","author":"Y Song","year":"2004","unstructured":"Y. Song, M.J. Stampfer, S. Liu, Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 141(2), 137\u2013147 (2004)","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"9585_CR30","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1155\/MI\/2006\/12587","volume":"2006","author":"J Kahri","year":"2006","unstructured":"J. Kahri, A. Soro-Paavonen, C. Ehnholm, M.R. Taskinen, ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects. Mediators Inflamm. 2006(3), 12587 (2006)","journal-title":"Mediators Inflamm."},{"issue":"23","key":"9585_CR31","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ehj.2004.08.024","volume":"25","author":"W Marz","year":"2004","unstructured":"W. Marz, H. Scharnagl, M.M. Hoffmann, B.O. Boehm, B.R. Winkelmann, The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur. Heart J. 25(23), 2109\u20132119 (2004)","journal-title":"Eur. Heart J."},{"issue":"6","key":"9585_CR32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0008-6363(95)00163-8","volume":"30","author":"P Delafontaine","year":"1995","unstructured":"P. Delafontaine, Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc. Res. 30(6), 825\u2013834 (1995)","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"9585_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.RES.83.1.50","volume":"83","author":"A Cittadini","year":"1998","unstructured":"A. Cittadini, Y. Ishiguro, H. Stromer, M. Spindler, A.C. Moses, R. Clark, P.S. Douglas, J.S. Ingwall, J.P. Morgan, Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ. Res. 83(1), 50\u201359 (1998)","journal-title":"Circ. Res."},{"issue":"3","key":"9585_CR34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2003-0009","volume":"24","author":"RN Clayton","year":"2003","unstructured":"R.N. Clayton, Cardiovascular function in acromegaly. Endocr. Rev. 24(3), 272\u2013277 (2003)","journal-title":"Endocr. Rev."},{"issue":"Suppl 1","key":"9585_CR35","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S1521-690X(09)70006-5","volume":"23","author":"A Colao","year":"2009","unstructured":"A. Colao, 5 Long-term acromegaly and associated cardiovascular complications: a case-based review. Best Pract. Res. 23(Suppl 1), S31\u2013S38 (2009)","journal-title":"Best Pract. Res."},{"issue":"1","key":"9585_CR36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosis.2010.10.017","volume":"214","author":"A Kablak-Ziembicka","year":"2011","unstructured":"A. Kablak-Ziembicka, T. Przewlocki, A. Sokolowski, W. Tracz, P. Podolec, Carotid intima-media thickness, hs-CRP and TNF-alpha are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis 214(1), 185\u2013190 (2011)","journal-title":"Atherosclerosis"},{"doi-asserted-by":"crossref","unstructured":"H. Ozkan, O. Celik, E. Hatipoglu, F. Kantarci, P. Kadioglu, Procalcitonin can be used as a marker of premature atherosclerosis in acromegaly. Pituitary (2011). doi: 10.1007\/s11102-011-0327-y","key":"9585_CR37","DOI":"10.1007\/s11102-011-0327-y"},{"issue":"5","key":"9585_CR38","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1210\/jc.2010-2225","volume":"96","author":"AN Paisley","year":"2011","unstructured":"A.N. Paisley, M. Banerjee, M. Rezai, R.E. Schofield, S. Balakrishnannair, A. Herbert, J.A. Lawrance, P.J. Trainer, J.K. Cruickshank, Changes in arterial stiffness but not carotid intimal thickness in acromegaly. J. Clin. Endocrinol. Metab. 96(5), 1486\u20131492 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"9585_CR39","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2265.2001.01281.x","volume":"54","author":"M Otsuki","year":"2001","unstructured":"M. Otsuki, S. Kasayama, H. Yamamoto, H. Saito, S. Sumitani, H. Kouhara, Y. Saitoh, T. Ohnishi, N. Arita, Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. Clin. Endocrinol. 54(6), 791\u2013796 (2001)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"9585_CR40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/STROKEAHA.107.488866","volume":"39","author":"L Paternoster","year":"2008","unstructured":"L. Paternoster, N.A. Martinez Gonzalez, S. Lewis, C. Sudlow, Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke. Stroke 39(1), 48\u201354 (2008)","journal-title":"Stroke"},{"issue":"2","key":"9585_CR41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2005.11.020","volume":"188","author":"IJ Andersson","year":"2006","unstructured":"I.J. Andersson, A. Ljungberg, L. Svensson, L.M. Gan, J. Oscarsson, G. Bergstrom, Increased atherosclerotic lesion area in apoE deficient mice overexpressing bovine growth hormone. Atherosclerosis 188(2), 331\u2013340 (2006)","journal-title":"Atherosclerosis"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-011-9585-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9585-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T17:05:24Z","timestamp":1742144724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-011-9585-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,27]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9585"],"URL":"https:\/\/doi.org\/10.1007\/s12020-011-9585-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2011,12,27]]}}}